BetterScholar BetterScholar
13
Role
Title
Level Year L/R
🐜 Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial
13 auth. L. Hansson, L. Lindholm, L. Niskanen, J. Lanke, T. Hedner, A. Niklason, K. Luomanmäki, B. Dahlöf, U. Faire, C. Mörlin, ... B. Karlberg, P.-O. Wester, Jan-Erik Björck
10 1999
10
🐜
🐜 Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
9 auth. L. Hansson, L. Lindholm, T. Ekbom, B. Dahlöf, J. Lanke, B. Scherstén, ... P. Wester, T. Hedner, U. Faire
10 1999
10
🐜
🐜 Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans
30 auth. S. Kathiresan, S. Kathiresan, O. Melander, C. Guiducci, Aarti Surti, N. Burtt, M. Rieder, G. Cooper, C. Roos, B. Voight, B. Voight, A. Havulinna, B. Wahlstrand, T. Hedner, D. Corella, ... E. Tai, J. Ordovás, G. Berglund, E. Vartiainen, P. Jousilahti, B. Hedblad, M. Taskinen, C. Newton‐Cheh, C. Newton‐Cheh, V. Salomaa, L. Peltonen, L. Groop, L. Groop, D. Altshuler, M. Orho-Melander
10 2008
10
🐜
🐜 Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study
10 auth. L. Hansson, T. Hedner, P. Lund-johansen, S. Kjeldsen, L. Lindholm, J. Syvertsen, ... J. Lanke, U. Faire, B. Dahlöf, B. Karlberg
9 2000
9
🐜
🐬 Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point.
L. Hansson, T. Hedner, B. Dahlöf
9 1992
9
🐬
🐬 Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension?
J. Hedner, H. Ejnell, J. Sellgren, T. Hedner, G. Wallin
8 1988
8
🐬
🐜 The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
15 auth. B. Dahlöf, R. Devereux, U. Faire, F. Fyhrquist, T. Hedner, H. Ibsen, S. Julius, S. Kjeldsen, K. Kristianson, O. Lederballe‐Pedersen, ... L. Lindholm, M. Nieminen, P. Omvik, S. Oparil, H. Wedel
8 1997
8
🐜
🐜 Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures
11 auth. E. Ben-Menachem, A. Hamberger, T. Hedner, E. Hammond, B. Uthman, J. Slater, ... T. Treig, H. Stefan, R. Ramsay, J. Wernicke, B. Wilder
8 1995
8
🐜
🐜 Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.
16 auth. B. Dahlöf, R. B. Devereux, S. Julius, S. Kjeldsen, G. Beevers, U. Faire, F. Fyhrquist, T. Hedner, H. Ibsen, K. Kristianson, ... O. Lederballe‐Pedersen, L. Lindholm, M. Nieminen, P. Omvik, S. Oparil, H. Wedel
8 1998
8
🐜
🐜 Common Missense Variant in the Glucokinase Regulatory Protein Gene Is Associated With Increased Plasma Triglyceride and C-Reactive Protein but Lower Fasting Glucose Concentrations
41 auth. M. Orho-Melander, O. Melander, C. Guiducci, P. Pérez-Martínez, D. Corella, C. Roos, R. Tewhey, M. Rieder, Jennifer L. Hall, G. Abecasis, E. Tai, C. Welch, D. Arnett, V. Lyssenko, E. Lindholm, ... R. Saxena, P. D. de Bakker, N. Burtt, B. Voight, J. Hirschhorn, K. Tucker, T. Hedner, T. Tuomi, B. Isomaa, K. Eriksson, M. Taskinen, B. Wahlstrand, T. Hughes, L. Parnell, Chao-Qiang Lai, G. Berglund, L. Peltonen, E. Vartiainen, P. Jousilahti, A. Havulinna, V. Salomaa, P. Nilsson, L. Groop, D. Altshuler, J. Ordovás, S. Kathiresan
8 2008
8
🐜
🐬 Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P
R. Björkman, K. Hallman, J. Hedner, T. Hedner, M. Henning
7 1994
7
🐬
🐬 Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project.
L. Niskanen, T. Hedner, L. Hansson, J. Lanke, A. Niklason
7 2001
7
🐬
🐬 Survival in treated hypertension: follow up study after two decades
O. Andersson, T. Almgren, Bengt Persson, O. Samuelsson, T. Hedner, L. Wilhelmsen
7 1998
7
🐬